What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Antibiotics
His main research concerns Internal medicine, Pneumonia, Surgery, Bacteremia and Intensive care medicine.
His Drug resistance research extends to Internal medicine, which is thematically connected.
His Pneumonia research integrates issues from Respiratory disease, Epidemiology and Streptococcus pneumoniae.
His research in Surgery intersects with topics in Case fatality rate, Incidence and Etiology.
His research integrates issues of Gastroenterology, Cancer, Antibacterial agent and Transplantation in his study of Bacteremia.
His work deals with themes such as Aspiration pneumonia, Solid organ transplantation, Logistic regression and Staphylococcus aureus, which intersect with Intensive care medicine.
His most cited work include:
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society (1288 citations)
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. (391 citations)
- Health Care–Associated Pneumonia Requiring Hospital Admission: Epidemiology, Antibiotic Therapy, and Clinical Outcomes (298 citations)
What are the main themes of his work throughout his whole career to date?
Jordi Carratalà focuses on Internal medicine, Pneumonia, Intensive care medicine, Surgery and Community-acquired pneumonia.
His studies link Bacteremia with Internal medicine.
His Bacteremia research incorporates elements of Cancer, Drug resistance and Risk factor.
While the research belongs to areas of Pneumonia, Jordi Carratalà spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Gastroenterology.
In his research on the topic of Intensive care medicine, Organ transplantation is strongly related with Solid organ transplantation.
His Surgery research is multidisciplinary, relying on both Incidence and Etiology.
He most often published in these fields:
- Internal medicine (60.78%)
- Pneumonia (27.45%)
- Intensive care medicine (25.93%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (60.78%)
- Pneumonia (27.45%)
- Clinical endpoint (9.80%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Pneumonia, Clinical endpoint, Intensive care medicine and Community-acquired pneumonia.
Internal medicine is frequently linked to Bacteremia in his study.
Jordi Carratalà has researched Bacteremia in several fields, including Cancer, Mortality rate, Methicillin-resistant Staphylococcus aureus and Daptomycin.
His Pneumonia study combines topics from a wide range of disciplines, such as Streptococcus pneumoniae, Antibody, Immunology, Viral pneumonia and Transplantation.
Jordi Carratalà interconnects Adverse effect and Intensive care in the investigation of issues within Clinical endpoint.
Jordi Carratalà has included themes like Clinical microbiology, Solid organ transplantation, Aspergillosis and Sepsis in his Intensive care medicine study.
Between 2018 and 2021, his most popular works were:
- Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. (66 citations)
- Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19). (34 citations)
- Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance. (19 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Antibiotics
Internal medicine, Pneumonia, Odds ratio, Clinical endpoint and Prospective cohort study are his primary areas of study.
The concepts of his Internal medicine study are interwoven with issues in Bacteremia, Antibiotics, Drug resistance and Staphylococcus aureus.
His Antibiotics research includes themes of Febrile neutropenia and Neutropenia.
His study on Community-acquired pneumonia is often connected to Antibiotic prescription as part of broader study in Pneumonia.
His Odds ratio study integrates concerns from other disciplines, such as Antibiotic sensitivity and Confidence interval.
His Clinical endpoint research is multidisciplinary, incorporating perspectives in Hydroxychloroquine, Cause of death, Lopinavir and Intensive care.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
